Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors

		Keywords:		Modafinil

		Phase:		Not Specified

		Treatment ID#s:		VT1721 NCT00052286

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		05/29/2006

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Brainstem Glioma Ependyoma Germ Cell Tumors Glioblastoma Multiforme Gliosarcoma Hemangioblastoma Low Grade Glioma Lymphomas Medulloblastoma Meningioma Metastatic Brain Tumor Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade Pituitary Tumors


		Comments:		Modafinil may be effective in relieving fatigue and improving behavioral changes such as memory loss in patients who have undergone treatment for primary brain cancer. The effectiveness of modafinil in relieving fatigue and improving behavioral change is not yet known.

		Treatment Type:		Less-Toxics.

		Contact:		Jonsson Comprehensive Cancer Center Thomas A. Kaleita, PhD UCLA Los Angeles, CA 90095 Phone:310-825-9989 Email not available

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By